Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsuneyuki Oda

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Internal Medicine (Tokyo, Japan)|August 2, 2023
Bilateral Pneumothorax after a Transbronchial Lung Cryobiopsy for Interstitial Lung DiseaseKazuhiro Nishiyama, Tomohisa Baba, Tsuneyuki Oda, et al.
General Thoracic and Cardiovascular Surgery|June 24, 2026
Unilateral upper-lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosis after lung cancer surgery: prolonged pleural effusion and pleural thickening as early postoperative indicatorsAkimasa Sekine, Kenji Inafuku, Masashi Nishimura, et al.
Respiratory Investigation|April 7, 2022
Clinical characteristics of pulmonary hypertension in patients with pleuroparenchymal fibroelastosisYutaka Muto, Akimasa Sekine, Eri Hagiwara, et al.
Scientific Reports|September 9, 2017
Low body surface area predicts hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosisSatoshi Ikeda, Akimasa Sekine, Tomohisa Baba, et al.
Respiratory Investigation|June 26, 2021
Asbestos exposure and tuberculous pleurisy as developmental causes of progressive unilateral upper-lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosisAkimasa Sekine, Eri Hagiwara, Tae Iwasawa, et al.
BMC Pulmonary Medicine|April 13, 2019
Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosisSatoshi Ikeda, Akimasa Sekine, Tomohisa Baba, et al.
Medicine|June 6, 2022
Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administrationSatoshi Ikeda, Akimasa Sekine, Tomohisa Baba, et al.
Thoracic Cancer|July 15, 2022
Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapyAkimasa Sekine, Goushi Matama, Eri Hagiwara, et al.
Respiratory Investigation|August 3, 2025
Incidence and risk factors of unilateral upper-lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosis after lung cancer surgery in interstitial lung disease patientsMasashi Nishimura, Akimasa Sekine, Kenji Inafuku, et al.
Respiratory Investigation|September 15, 2023
High prevalence of upper lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosis in patients with round atelectasisAkimasa Sekine, Eri Hagiwara, Tsuneyuki Oda, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Internal Medicine (Tokyo, Japan)|August 2, 2023
Bilateral Pneumothorax after a Transbronchial Lung Cryobiopsy for Interstitial Lung DiseaseKazuhiro Nishiyama, Tomohisa Baba, Tsuneyuki Oda, et al.
General Thoracic and Cardiovascular Surgery|June 24, 2026
Unilateral upper-lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosis after lung cancer surgery: prolonged pleural effusion and pleural thickening as early postoperative indicatorsAkimasa Sekine, Kenji Inafuku, Masashi Nishimura, et al.
Respiratory Investigation|April 7, 2022
Clinical characteristics of pulmonary hypertension in patients with pleuroparenchymal fibroelastosisYutaka Muto, Akimasa Sekine, Eri Hagiwara, et al.
Scientific Reports|September 9, 2017
Low body surface area predicts hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosisSatoshi Ikeda, Akimasa Sekine, Tomohisa Baba, et al.
Respiratory Investigation|June 26, 2021
Asbestos exposure and tuberculous pleurisy as developmental causes of progressive unilateral upper-lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosisAkimasa Sekine, Eri Hagiwara, Tae Iwasawa, et al.
BMC Pulmonary Medicine|April 13, 2019
Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosisSatoshi Ikeda, Akimasa Sekine, Tomohisa Baba, et al.
Medicine|June 6, 2022
Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administrationSatoshi Ikeda, Akimasa Sekine, Tomohisa Baba, et al.
Thoracic Cancer|July 15, 2022
Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapyAkimasa Sekine, Goushi Matama, Eri Hagiwara, et al.
Respiratory Investigation|August 3, 2025
Incidence and risk factors of unilateral upper-lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosis after lung cancer surgery in interstitial lung disease patientsMasashi Nishimura, Akimasa Sekine, Kenji Inafuku, et al.
Respiratory Investigation|September 15, 2023
High prevalence of upper lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosis in patients with round atelectasisAkimasa Sekine, Eri Hagiwara, Tsuneyuki Oda, et al.
Pageof 5